Igurati-25 Tablet

Igurati-25 Tablet

Igurati-25 Tablet contains Iguratimod 25mg, an oral disease-modifying antirheumatic drug (DMARD) manufactured by Ipca Laboratories used to manage rheumatoid arthritis in adults. It works through a dual mechanism, suppressing inflammatory cytokine production and modulating immune cell activity, helping reduce joint inflammation and slow the progression of joint damage over time.

Key Features

• Contains Iguratimod 25mg, a dual-action oral DMARD
• Helps reduce joint inflammation and pain in rheumatoid arthritis
• Slows progression of joint damage with regular use
• Supports long-term disease management under specialist care
• Trusted formulation from Ipca Laboratories
• Strip of 10 tablets

Key Ingredients

• Iguratimod 25mg

Uses

Prescribed for the management of rheumatoid arthritis and related inflammatory conditions as directed by a physician or specialist. It may be used alone or in combination with methotrexate or other DMARDs as part of a comprehensive rheumatoid arthritis management plan tailored by your rheumatologist.

Directions for Use

Take exactly as prescribed by your physician, typically once or twice daily, maintaining consistent use for best therapeutic outcomes.

Precautions

• Use only as prescribed by a registered physician/specialist
• Regular liver function and blood count monitoring is typically recommended during treatment, especially during the initial months.
• Inform your doctor of any existing conditions, infections, or allergies before starting treatment
• Keep away from children

Legal Disclaimer: The product is guaranteed to be 100% genuine. Product images are for illustrative purposes only. This is a prescription medication; use only under medical supervision.